CD8A and neoplasm: As shown above, while in CD8 TILs from renal cell carcinoma, high levels of ROS led to impairment and lack of anti-tumor response, high levels of ROS in TILs from mice with colon carcinoma treated with anti-PD-1 blockade were associated with increased tumoricidal effects.